UNSPSC 51282955: Esafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C15H17FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A6NT0I9X0K, chemically known as 1,8-naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo- but more generally known as esafloxacin, which bears US NIH Compound Identifier 208933. European Medicines Agency schedules Esafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06606MIG.

The term ESAFLOXACIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). ESAFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: FC1C(N2CC(N)CC2)NC2N(CC)CC(C(=O)C2C1)C(=O)O.

UNSPSC 51282955 Esafloxacin, a Commodity code, shows minimal recent state and local procurement activity aligned with the drug's nominal scope. The two recent opportunities tagged to this code do not solicit esafloxacin itself. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—different fluoroquinolone and tetracycline antibiotics—with a total award of $2,999,999.11 over three years including renewals. Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems, neither of which are esafloxacin or related antimicrobials. The mismatch suggests that state and local procurement offices are not currently soliciting esafloxacin under this code, or that recent purchases have been absorbed through existing vendor contracts and cooperative-purchasing vehicles without new open solicitations.

The Illinois and Florida records represent the only recent activity indexed to this code in the source. Illinois Department of Public Health and Seminole County are the only issuing bodies shown; both solicited through competitive processes (an IFB for Illinois and an IFB for Florida). No open solicitations for esafloxacin or related fluoroquinolone antibiotics appear in the current dataset. Firms pursuing pharmaceutical supply contracts at the state and local level should monitor related antibiotic and antimicrobial codes and track cooperative purchasing consortia such as MMCAP Infuse that aggregate state health department and county community health demand.